Phenyl pyrrolidine ether tachykinin receptor antagonists

Details for Australian Patent Application No. 2004277932 (hide)

Owner Merck & Co., Inc.

Inventors Devita, Robert J.; Young, Jonathan R.; Lin, Peter; Mills, Sander G.

Agent Spruson & Ferguson

Pub. Number AU-B-2004277932

PCT Pub. Number WO2005/032464

Priority 60/507,211 30.09.03 US

Filing date 24 September 2004

Wipo publication date 14 April 2005

Acceptance publication date 16 July 2009

International Classifications

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

C07D 207/04 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 413/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/032464 Priority application(s): WO2005/032464

16 July 2009 Application Accepted

  Published as AU-B-2004277932

12 November 2009 Standard Patent Sealed

21 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004277934-Optimized expression of HPV 45 L1 in yeast

2004277928-Device and method for treatment of gases by a moving bed of particulate material